Pf4 bacteriophage produced by Pseudomonas aeruginosa inhibits Aspergillus fumigatus metabolism via iron sequestration

Microbiology (United Kingdom)

Volumn 162, Issue 9, 2016, Pages 1583-1594

  Penner, Jack C ^a,b,g   Ferreira, Jose A G ^a,b,h   Secor, Patrick R ^c   Sweere, Johanna M ^b,d   Birukova, Maria K ^b,d   Joubert, Lydia Marie ^b   Haagensen, Janus A J ^e   Garcia, Omar ^b   Malkovskiy, Andrey V ^b,d   Kaber, Gernot ^b   Nazik, Hasan ^a,b,f   Manasherob, Robert ^b   Spormann, Alfred M ^e   Clemons, Karl V ^a,b   Stevens, David A ^a,b   Bollyky, Paul L ^b,d  

^a CALIFORNIA INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d STANFORD UNIVERSITY   (United States)

^e Stanford University   (United States)

^f ISTANBUL UNIVERSITY   (Turkey)

^g GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h Department of Orthopedics and Traumatology   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

IRON;

ARTICLE; ASPERGILLUS FUMIGATUS; BACTERIOPHAGE; BACTERIOPHAGE PF4; BIOFILM; CONTROLLED STUDY; FUNGAL METABOLISM; FUNGUS HYPHAE; IN VITRO STUDY; METABOLIC INHIBITION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SURFACE PROPERTY; ASPERGILLOSIS; HUMAN; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; VIROLOGY;

ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BACTERIOPHAGES; BIOFILMS; HUMANS; IRON; PSEUDOMONAS AERUGINOSA;

EID: 84992386213     PISSN: 13500872     EISSN: 14652080     Source Type: Journal    
DOI: 10.1099/mic.0.000344     Document Type: Article

References (53)

1. Amin, R., Dupuis, A., Aaron, S. D. & Ratjen, F. (2010). The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis. Chest 137, 171–176.
2. Baxter, C. G., Rautemaa, R., Jones, A. M., Webb, A. K., Bull, M., Mahenthiralingam, E. & Denning, D. W. (2013). Intravenous antibiotics reduce the presence of Aspergillus in adult cystic fibrosis sputum. Thorax 68, 652–657.
3. Blyth, W. (1971). Modifications in the ultrastructure of Aspergillus fumigatus due to the presence of living cells of Pseudomonas aeruginosa. Sabouraudia 9, 283–286.
4. Botha, P., Archer, L., Anderson, R. L., Lordan, J., Dark, J. H., Corris, P. A., Gould, K. & Fisher, A. J. (2008). Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome. Transplantation 85, 771–774.
5. Boulanger, P. (2009). Purification of bacteriophages and SDS-PAGE analysis of phage structural proteins from ghost particles. Methods Mol Biol 502, 227–238.
6. Briard, B., Bomme, P., Lechner, B. E., Mislin, G. L. A., Lair, V., Prèvost, M.-C., Latgè, J.-P., Haas, H. & Beauvais, A. & other authors (2015). Pseudomonas aeruginosa manipulates redox and iron homeostasis of its microbiota partner Aspergillus fumigatus via phenazines. Sci Rep 5, 8220.
7. Cahill, B. C., Hibbs, J. R., Savik, K., Juni, B. A., Dosland, B. M., Edin-Stibbe, C. & Hertz, M. I. (1997). Aspergillus airway colonization and invasive disease after lung transplantation. Chest 112, 1160–1164.
8. Castang, S. & Dove, S. L. (2012). Basis for the essentiality of H-NS family members in Pseudomonas aeruginosa. J Bacteriol 194, 5101–5109.
9. Chen, Y. C., Wu, Y. T. & Wei, Y. H. (2015). Depletion of mitoferrins leads to mitochondrial dysfunction and impairment of adipogenic differentiation in 3T3-L1 preadipocytes. Free Radic Res 49, 1285–1295.
10. Clemons, K. V. & Stevens, D. A. (2009). Conventional or molecular measurement of Aspergillus load. Med Mycol 47, S132–137.
11. Costerton, J. W., Stewart, P. S. & Greenberg, E. P. (1999). Bacterial biofilms: a common cause of persistent infections. Science 284, 1318–1322.
12. Ferreira, J. A., Penner, J. C., Moss, R. B., Haagensen, J. A., Clemons, K. V., Spormann, A. M., Nazik, H., Cohen, K., Banaei, N. & other authors (2015). Inhibition of Aspergillus fumigatus and its biofilm by Pseudomonas aeruginosa is dependent on the source, phenotype and growth conditions of the bacterium. PLoS One 10, e0134692.
13. Fillaux, J., Brèmont, F., Murris, M., Cassaing, S., Rittiè, J. L., Tètu, L., Segonds, C., Abbal, M., Bieth, E. & other authors (2012). Assessment of Aspergillus sensitization or persistent carriage as a factor in lung function impairment in cystic fibrosis patients. Scand J Infect Dis 44, 842–847.
14. Finnan, S., Morrissey, J. P., O’Gara, F. & Boyd, E. F. (2004). Genome diversity of Pseudomonas aeruginosa isolates from cystic fibrosis patients and the hospital environment. J Clin Microbiol 42, 5783–5792.
15. Garantziotis, S. & Palmer, S. M. (2009). An unwelcome guest: Aspergillus colonization in lung transplantation and its association with bronchiolitis obliterans syndrome. Am J Transplant 9, 1705–1706.
16. Geday, M. A., Kaminsky, W., Lewis, J. G. & Glazer, A. M. (2000). Images of absolute retardance L.Dn, using the rotating polariser method. J Microsc 198, 1–9.
17. Govan, J. R. & Deretic, V. (1996). Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 60, 539–574.
18. Hall-Stoodley, L. & Stoodley, P. (2009). Evolving concepts in biofilm infections. Cell Microbiol 11, 1034–1043.
19. Hmelo, L. R., Borlee, B. R., Almblad, H., Love, M. E., Randall, T. E., Tseng, B. S., Lin, C., Irie, Y., Storek, K. M. & other authors (2015). Precision-engineering the Pseudomonas aeruginosa genome with two-step allelic exchange. Nat Protoc 10, 1820–1841.
20. Høiby, N., Ciofu, O. & Bjarnsholt, T. (2010). Pseudomonas aeruginosa biofilms in cystic fibrosis. Future Microbiol 5, 1663–1674.
21. Jacobs, M. A., Alwood, A., Thaipisuttikul, I., Spencer, D., Haugen, E., Ernst, S., Will, O., Kaul, R., Raymond, C. & other authors (2003). Comprehensive transposon mutant library of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 100, 14339–14344.
22. Janmey, P. A., Slochower, D. R., Wang, Y. H., Wen, Q. & Cebers, A. (2014). Polyelectrolyte properties of filamentous biopolymers and their consequences in biological fluids. Soft Matter 10, 1439–1449.
23. Kakizaki, I., Kojima, K., Takagaki, K., Endo, M., Kannagi, R., Ito, M., Maruo, Y., Sato, H., Yasuda, T. & other authors (2004). A novel mechanism for the inhibition of hyaluronan biosynthesis by 4-methylumbelliferone. J Biol Chem 279, 33281–33289.
24. Kaur, S. & Singh, S. (2014). Biofilm formation by Aspergillus fumigatus. Med Mycol 52, 2–9.
25. Kerr, J. R., Taylor, G. W., Rutman, A., Høiby, N., Cole, P. J. & Wilson, R. (1999). Pseudomonas aeruginosa pyocyanin and 1-hydroxyphenazine inhibit fungal growth. J Clin Pathol 52, 385–387.
26. Kirov, S. M., Webb, J. S., O’may, C. Y., Reid, D. W., Woo, J. K., Rice, S. A. & Kjelleberg, S. (2007). Biofilm differentiation and dispersal in mucoid Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Microbiology 153, 3264–3274.
27. Manavathu, E. K., Vager, D. L. & Vazquez, J. A. (2014). Development and antimicrobial susceptibility studies of in vitro monomicrobial and polymicrobial biofilm models with Aspergillus fumigatus and Pseudomonas aeruginosa. BMC Microbiol 14, 53.
28. Mangan, A. (1969). Interactions between some aural Aspergillus species and bacteria. J Gen Microbiol 58, 261–266.
29. Manos, J., Arthur, J., Rose, B., Tingpej, P., Fung, C., Curtis, M., Webb, J. S., Hu, H., Kjelleberg, S. & other authors (2008). Transcriptome analyses and biofilm-forming characteristics of a clonal Pseudomonas aeruginosa from the cystic fibrosis lung. J Med Microbiol 57, 1454–1465.
30. Mathee, K., Narasimhan, G., Valdes, C., Qiu, X., Matewish, J. M., Koehrsen, M., Rokas, A., Yandava, C. N., Engels, R. & other authors (2008). Dynamics of Pseudomonas aeruginosa genome evolution. Proc Natl Acad Sci U S A 105, 3100–3105.
31. Nazik, H., Penner, J. C., Ferreira, J. A., Haagensen, J. A., Cohen, K., Spormann, A. M., Martinez, M., Chen, V., Hsu, J. L. & other authors (2015). Effects of iron chelators on the formation and development of Aspergillus fumigatus biofilm. Antimicrob Agents Chemother 59, 6514–6520.
32. Nicolai, T., Arleth, S., Spaeth, A., Bertele-Harms, R. M. & Harms, H. K. (1990). Correlation of IgE antibody titer to Aspergillus fumigatus with decreased lung function in cystic fibrosis. Pediatr Pulmonol 8, 12–15.
33. Nunley, D. R., Ohori, P., Grgurich, W. F., Iacono, A. T., Williams, P. A., Keenan, R. J. & Dauber, J. H. (1998). Pulmonary aspergillosis in cystic fibrosis lung transplant recipients. Chest 114, 1321–1329.
34. Platt, M. D., Schurr, M. J., Sauer, K., Vazquez, G., Kukavica-Ibrulj, I., Potvin, E., Levesque, R. C., Fedynak, A., Brinkman, F. S. & other authors (2008). Proteomic, microarray, and signature-tagged mutagenesis analyses of anaerobic Pseudomonas aeruginosa at pH 6.5, likely representing chronic, late-stage cystic fibrosis airway conditions. J Bacteriol 190, 2739–2758.
35. Rakonjac, J., Bennett, N. J., Spagnuolo, J., Gagic, D. & Russel, M. (2011). Filamentous bacteriophage: biology, phage display and nanotechnology applications. Curr Issues Mol Biol 13, 51–76.
36. Ramsey, K. A., Ranganathan, S., Park, J., Skoric, B., Adams, A. M., Simpson, S. J., Robins-Browne, R. M., Franklin, P. J., de Klerk, N. H. & other authors (2014). Early respiratory infection is associated with reduced spirometry in children with cystic fibrosis. Am J Respir Crit Care Med 190, 1111–1116.
37. Reichhardt, C., Ferreira, J. A., Joubert, L. M., Clemons, K. V., Stevens, D. A. & Cegelski, L. (2015). Analysis of the Aspergillus fumigatus biofilm extracellular matrix by solid-state nuclear magnetic resonance spectroscopy. Eukaryot Cell 14, 1064–1072.
38. Reid, D. W., Carroll, V., O’May, C., Champion, A. & Kirov, S. M. (2007). Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis. Eur Respir J 30, 286–292.
39. Rex, J. H. (2008). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi, 2nd edn. Wayne, PA: CLSI.
40. Rowe, S. M., Miller, S. & Sorscher, E. J. (2005). Cystic fibrosis. N Engl J Med 352, 1992–2001.
41. Schønheyder, H., Jensen, T., Høiby, N., Andersen, P. & Koch, C. (1985). Frequency of Aspergillus fumigatus isolates and antibodies to Aspergillus antigens in cystic fibrosis. Acta Pathol Microbiol Immunol Scand B 93, 105–112.
42. Secor, P. R., Sweere, J. M., Michaels, L. A., Malkovskiy, A. V., Lazzareschi, D., Katznelson, E., Rajadas, J., Birnbaum, M. E., Arrigoni, A. & other authors (2015). Filamentous bacteriophage promote biofilm assembly and function. Cell Host Microbe 18, 549–559.
43. Shoseyov, D., Brownlee, K. G., Conway, S. P. & Kerem, E. (2006). Aspergillus bronchitis in cystic fibrosis. Chest 130, 222–226.
44. Singh, G., Imai, J., Clemons, K. V. & Stevens, D. A. (2005). Efficacy of caspofungin against central nervous system Aspergillus fumigatus infection in mice determined by TaqMan PCR and CFU methods. Antimicrob Agents Chemother 49, 1369–1376.
45. Speirs, J. J., van der Ent, C. K. & Beekman, J. M. (2012). Effects of Aspergillus fumigatus colonization on lung function in cystic fibrosis. Curr Opin Pulm Med 18, 632–638.
46. Stevens, D. A., Moss, R. B., Kurup, V. P., Knutsen, A. P., Greenberger, P., Judson, M. A., Denning, D. W., Crameri, R., Brody, A. S. & other authors (2003). Allergic bronchopulmonary aspergillosis in cystic fibrosis—state of the art: Cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis 37, S225–264.
47. Tang, J. X., Janmey, P. A., Lyubartsev, A. & Nordenskiöld, L. (2002). Metal ion-induced lateral aggregation of filamentous viruses fd and M13. Biophys J 83, 566–581.
48. Webb, J. S., Lau, M. & Kjelleberg, S. (2004). Bacteriophage and phenotypic variation in Pseudomonas aeruginosa biofilm development. J Bacteriol 186, 8066–8073.
49. Whitchurch, C. B., Tolker-Nielsen, T., Ragas, P. C. & Mattick, J. S. (2002). Extracellular DNA required for bacterial biofilm formation. Science 295, 1487.
50. Winstanley, C., Langille, M. G., Fothergill, J. L., Kukavica-Ibrulj, I., Paradis-Bleau, C., Sanschagrin, F., Thomson, N. R., Winsor, G. L., Quail, M. A. & other authors (2009). Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool epidemic strain of Pseudomonas aeruginosa. Genome Res 19, 12–23.
51. Yeldandi, V., Laghi, F., Larson, R., Husain, A., Garrity, E. R., Husain, A., Montoya, A. & Garrity, E. R. (1995). Aspergillus and lung transplantation. J Heart Lung Transplant 14, 883–890.
52. Yeung, A. T., Torfs, E. C., Jamshidi, F., Bains, M., Wiegand, I., Hancock, R. E. & Overhage, J. (2009). Swarming of Pseudomonas aeruginosa is controlled by a broad spectrum of transcriptional regulators, including MetR. J Bacteriol 191, 5592–5602.
53. Zimmermann, K., Hagedorn, H., Heuck, C. C., Hinrichsen, M. & Ludwig, H. (1986). The ionic properties of the filamentous bacteriophages Pf1 and fd. J Biol Chem 261, 1653–1655.